Trial record 2 of 159 for:    Open Studies | "Lung Diseases, Interstitial"

UPMC Simmons Center for Interstitial Lung Disease Pennsylvania Statewide Research Registry (ILDRR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2012 by University of Pittsburgh
Sponsor:
Information provided by (Responsible Party):
Naftali Kaminski, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00258583
First received: November 23, 2005
Last updated: June 22, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to place past, current, and future medical record information into the UPMC Simmons Center for Interstitial Lung Disease Research Registry.


Condition
Lung Diseases, Interstitial

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: UPMC Simmons Center for Interstitial Lung Disease Pennsylvania Statewide Research Registry

Resource links provided by NLM:


Further study details as provided by University of Pittsburgh:

Estimated Enrollment: 1000
Study Start Date: October 2003
Estimated Study Completion Date: July 2015
Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Detailed Description:

This study gives participant's permission to allow the staff at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease to to place past, current, and future medical record information into a UPMC Simmons Center for Interstitial Lung Disease Research Registry. By placing the medical record information of many patients into a research registry, researchers will be able to conduct research studies directed at increasing our knowledge about interstitial lung disease. It is anticipated that the research registry will assist out investigators by allowing researchers to review and study the medical records of many individuals to answer questions about interstitial lung disease and its treatment. In addition, it will help researchers identify and recruit patients for participation in future research studies.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Study population can be described as any adult being seen by a physician at the Simmons Center for interstitial lung disease who has been diagnosed with an Interstitial Lung Disease.

Criteria

Inclusion Criteria:

  • Adult patients who are seeking treatment at the UPMC Simmons Center for Interstitial Lung Disease
  • 18 years of age or older

Exclusion Criteria:

  • N/A
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00258583

Contacts
Contact: Melinda J Klesen, BA 412-802-6860 ext 26860 klesenmj@upmc.edu
Contact: Trisha R Black, BA 412-605-1550 ext 51550 blacktr@upmc.edu

Locations
United States, Pennsylvania
University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Sub-Investigator: Rajiv Dhir, MD         
Sub-Investigator: Steven Duncan, MD         
Sub-Investigator: Kevin Gibson, MD         
Sub-Investigator: Robert M Hoffman, MD         
Sub-Investigator: Kathleen Lindell, MSN, RN         
Sub-Investigator: Luis A Ortiz, MD         
Sub-Investigator: Melinda J Klesen, BA         
Sub-Investigator: Trisha R Black, B.A.         
Sub-Investigator: Michelle F MacPherson, BS, MAT         
Sub-Investigator: Daniel J. Kass, M.D         
Sub-Investigator: Kristen Veraldi, M.D.         
Sub-Investigator: Michelle Meyers, BSN, RN         
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: Naftali Kaminski, MD University of Pittsburgh - UPMC Simmons Center for Interstitial Lung Disease
  More Information

No publications provided

Responsible Party: Naftali Kaminski, Director, The Lung, Blood and Vascular Center for Genomic Medicine in the Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00258583     History of Changes
Other Study ID Numbers: 0307127
Study First Received: November 23, 2005
Last Updated: June 22, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
"Lung[A04.400]"

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 28, 2014